Cargando…
Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity
Curative therapeutic options for a number of immunological disorders remain to be established, and approaches for identifying drug candidates are relatively limited. Furthermore, phenotypic screening methods using induced pluripotent stem cell (iPSC)-derived immune cells or hematopoietic cells need...
Autores principales: | Seki, Ryosuke, Ohta, Akira, Niwa, Akira, Sugimine, Yoshinori, Naito, Haruna, Nakahata, Tatsutoshi, Saito, Megumu K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437452/ https://www.ncbi.nlm.nih.gov/pubmed/32810141 http://dx.doi.org/10.1371/journal.pone.0237030 |
Ejemplares similares
-
Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity
por: Seki, Ryosuke, et al.
Publicado: (2021) -
Pluripotent stem cell‐based screening identifies CUDC‐907 as an effective compound for restoring the in vitro phenotype of Nakajo‐Nishimura syndrome
por: Kase, Naoya, et al.
Publicado: (2020) -
Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification
por: Matsuo, Shiori, et al.
Publicado: (2021) -
Diagnosis of NLRP3 somatic mosaicism in CINCA/NOMID patients using next-generation sequencing
por: Izawa, K, et al.
Publicado: (2011) -
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells
por: Ohta, Ryo, et al.
Publicado: (2016)